Taiwan FDA registration b2e1596a2316b025fb3c68735c0cf563

"Bidi" anti-carba (immunoglobulin light chain) reagent

TW: "必帝" 抗卡巴(免疫球蛋白輕鏈)試劑
Taiwan flagTaiwan·Risk Class 2·BD BIOSCIENCES IMMUNOCYTOMETRY SYSTEMS, A UNIT OF BECTON, DICKINSON AND COMPANY·Registered Mar 15, 2006 – Mar 15, 2011Cancelled
Registration details
Analysis ID
b2e1596a2316b025fb3c68735c0cf563
Customs Code
DHA00601615400
Company information
Manufacturer Country
United States
Product details
Intended Use
Specifically identifies human immunoglobulin carba light chain antigens.
Product Type (Level 1)
C Immunology and microbiology
Product Type (Level 2)
C.5550 Immunoglobulin (Specific Light Chain) Immunoassay System
Import Information
import
Dates and status
Registration Date
Mar 15, 2006
Expiry Date
Mar 15, 2011
Cancellation Date
Oct 26, 2012
Cancellation information
Status
Logged out
Reason
許可證已逾有效期
About this record

Access comprehensive regulatory information for "Bidi" anti-carba (immunoglobulin light chain) reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number b2e1596a2316b025fb3c68735c0cf563 and manufactured by BD BIOSCIENCES IMMUNOCYTOMETRY SYSTEMS, A UNIT OF BECTON, DICKINSON AND COMPANY. The authorized representative in Taiwan is Taiwan Branch of American Business Bidi Co., Ltd.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices